BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38225758)

  • 1. Performance and Sensitivity of [
    Hernández-Lozano I; Leterrier S; Mairinger S; Stanek J; Zacher AS; Breyer L; Hacker M; Zeitlinger M; Pahnke J; Tournier N; Wanek T; Langer O
    Mol Pharm; 2024 Feb; 21(2):932-943. PubMed ID: 38225758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Governing P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier Measured with Positron Emission Tomography.
    Wanek T; Römermann K; Mairinger S; Stanek J; Sauberer M; Filip T; Traxl A; Kuntner C; Pahnke J; Bauer F; Erker T; Löscher W; Müller M; Langer O
    Mol Pharm; 2015 Sep; 12(9):3214-25. PubMed ID: 26202880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Mairinger S; Leterrier S; Filip T; Löbsch M; Pahnke J; Hernández-Lozano I; Stanek J; Tournier N; Zeitlinger M; Hacker M; Langer O; Wanek T
    J Cereb Blood Flow Metab; 2024 Jan; 44(1):142-152. PubMed ID: 37728771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Resistance Protein and P-Glycoprotein Influence In Vivo Disposition of 11C-Erlotinib.
    Traxl A; Wanek T; Mairinger S; Stanek J; Filip T; Sauberer M; Müller M; Kuntner C; Langer O
    J Nucl Med; 2015 Dec; 56(12):1930-6. PubMed ID: 26359257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of P-glycoprotein on pulmonary disposition of the model substrate [
    Mairinger S; Hernández-Lozano I; Filip T; Löbsch M; Stanek J; Zeitlinger M; Hacker M; Tournier N; Wanek T; Ehrhardt C; Langer O
    Eur J Pharm Sci; 2023 Apr; 183():106404. PubMed ID: 36773747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring interactions at ATP-dependent drug efflux pumps.
    Hendrikse NH
    Curr Pharm Des; 2000 Nov; 6(16):1653-68. PubMed ID: 10974159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of breast cancer resistance protein and P-glycoprotein on tissue distribution and excretion of Ko143 assessed with PET imaging in mice.
    Mairinger S; Zoufal V; Wanek T; Traxl A; Filip T; Sauberer M; Stanek J; Kuntner C; Pahnke J; Müller M; Langer O
    Eur J Pharm Sci; 2018 Mar; 115():212-222. PubMed ID: 29360507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging to assess the impact of P-glycoprotein on pulmonary drug delivery in rats.
    Hernández-Lozano I; Mairinger S; Filip T; Sauberer M; Wanek T; Stanek J; Sake JA; Pekar T; Ehrhardt C; Langer O
    J Control Release; 2022 Feb; 342():44-52. PubMed ID: 34971693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of P-glycoprotein function inhibition with cyclosporine A on the biodistribution of Tc-99m sestamibi.
    Kabasakal L; Halaĉ M; Nisli C; Oguz O; Onsel C; Civi G; Uslu I
    Clin Nucl Med; 2000 Jan; 25(1):20-3. PubMed ID: 10634525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier.
    Vlaming ML; Läppchen T; Jansen HT; Kivits S; van Driel A; van de Steeg E; van der Hoorn JW; Sio CF; Steinbach OC; DeGroot J
    Nucl Med Biol; 2015 Nov; 42(11):833-41. PubMed ID: 26264927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [
    Hernández Lozano I; Bauer M; Wulkersdorfer B; Traxl A; Philippe C; Weber M; Häusler S; Stieger B; Jäger W; Mairinger S; Wanek T; Hacker M; Zeitlinger M; Langer O
    Mol Pharm; 2020 Jan; 17(1):316-326. PubMed ID: 31790256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
    Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
    J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein.
    Seneca N; Zoghbi SS; Liow JS; Kreisl W; Herscovitch P; Jenko K; Gladding RL; Taku A; Pike VW; Innis RB
    J Nucl Med; 2009 May; 50(5):807-13. PubMed ID: 19372478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma.
    Kim YS; Cho SW; Lee KJ; Hahm KB; Wang HJ; Yim H; Jin YM; Park CH
    Clin Nucl Med; 1999 Nov; 24(11):874-9. PubMed ID: 10551471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sestamibi is a substrate for MDR1 and MDR2 P-glycoprotein genes.
    Joseph B; Bhargava KK; Malhi H; Schilsky ML; Jain D; Palestro CJ; Gupta S
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1024-31. PubMed ID: 12536246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nude mice multi-drug resistance model of orthotopic transplantation of liver neoplasm and Tc-99m MIBI SPECT on p-glycoprotein.
    Han Y; Chen XP; Huang ZY; Zhu H
    World J Gastroenterol; 2005 Jun; 11(22):3335-8. PubMed ID: 15948235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the in vitro and in vivo properties of a (99m)Tc-labeled inhibitor of the multidrug resistant gene product P-glycoprotein.
    Bergmann R; Brust P; Scheunemann M; Pietzsch HJ; Seifert S; Roux F; Johannsen B
    Nucl Med Biol; 2000 Feb; 27(2):135-41. PubMed ID: 10773542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (99m)Tc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study.
    Bolzati C; Carta D; Gandin V; Marzano C; Morellato N; Salvarese N; Cantore M; Colabufo NA
    J Biol Inorg Chem; 2013 Jun; 18(5):523-38. PubMed ID: 23543234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Functional Redundancy between P-gp and BCRP in Controlling the Brain Distribution and Biliary Excretion of Dual Substrates with PET Imaging in Mice.
    Hernández-Lozano I; Mairinger S; Traxl A; Sauberer M; Filip T; Stanek J; Kuntner C; Wanek T; Langer O
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parametric Imaging of P-Glycoprotein Function at the Blood-Brain Barrier Using k
    Breuil L; El Biali M; Vodovar D; Marie S; Auvity S; Bauer M; Goutal S; Rodrigo S; Langer O; Tournier N
    Mol Imaging Biol; 2023 Dec; 25(6):1135-1141. PubMed ID: 37801196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.